Electromed, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Electromed, Inc. (ELMD) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $13.04 per share for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-25.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-08-25
- Electromed, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2022-09-30 was $9.90, a 13.16% decline year-over-year.
- Electromed, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2021-09-30 was $11.40.
- Electromed, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2026 was $13.04, a 37.26% increase from fiscal 2025.
- Electromed, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2025 was $9.50, a 64.36% increase from fiscal 2024.
- Electromed, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2024 was $5.78.
- Electromed, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2015 was $0.95, a 7.95% increase from fiscal 2014.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2026-06-30 | $13.04 10-K · filed 2026-08-25 | |||
| 2025-06-30 | $9.50 10-K · filed 2026-08-25 | |||
| 2024-06-30 | $5.78 10-K · filed 2025-08-26 | |||
| 2023-03-31 | $9.93 10-Q · filed 2023-05-09 | |||
| 2022-12-31 | $9.91 10-Q · filed 2023-02-14 | |||
| 2022-09-30 | $9.90 10-Q · filed 2022-11-08 | |||
| 2022-03-31 | $11.52 10-Q · filed 2022-05-10 | |||
| 2021-09-30 | $11.40 10-Q · filed 2021-11-09 | |||
| 2015-06-30 | $0.95 10-K · filed 2015-09-15 | |||
| 2014-06-30 | $0.88 10-K · filed 2015-09-15 | |||
| 2013-06-30 | $1.03 10-K · filed 2014-09-23 | |||
| 2012-06-30 | $1.48 10-K · filed 2013-09-25 | |||
| 2011-06-30 | $1.63 10-K · filed 2012-09-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EDAP TMS SA (FOCL) | $0.171B | ||
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |